Referred to the House Committee on Energy and Commerce.
This bill amends the Toxic Substances Control Act to add a new subsection that defines “commercial asbestos” (listing specific asbestiform minerals) and, effective on enactment, prohibits the manufacture, processing, use, and distribution in commerce of commercial asbestos and mixtures or articles containing it. The bill excludes materials where asbestos is only an impurity, allows end-use of asbestos-containing articles installed in buildings or equipment before enactment and distribution solely for disposal, and limits these changes to TSCA’s chemical-substance regulatory authority without altering other statutory asbestos rules (for example under the FD&C Act).
Public health vs. economic impact: liberals emphasize health benefits; conservatives emphasize costs and disruption.
Relative to its intended legislative type, this bill is a clear and specific substantive amendment to TSCA establishing a broad prohibition on commercial asbestos with defined scope, exemptions, and procedural requirements.
This bill amends the Toxic Substances Control Act to add a new subsection that defines “commercial asbestos” (listing specific asbestiform minerals) and, effective on enactment, prohibits the manufacture, processing, use, and distribution in commerce of commercial asbestos and mixtures or articles containing it.
The bill excludes materials where asbestos is only an impurity, allows end-use of asbestos-containing articles installed in buildings or equipment before enactment and distribution solely for disposal, and limits these changes to TSCA’s chemical-substance regulatory authority without altering other statutory asbestos rules (for example under the FD&C Act).
It creates a limited transition for chlor-alkali facilities in operation on the date of enactment to use asbestos diaphragms through January 1, 2030.
On content alone, this is a targeted public‑health regulatory ban with built‑in, narrowly tailored exemptions and few structural complexities — features that improve tractability. However, affected industrial interests, transition costs, litigation risk, and the lack of appropriations or implementation funding create friction. The bill's narrow scope and compromise elements increase plausibility of eventual enactment, but overcoming stakeholder opposition and securing bipartisan supermajorities where required (e.g., in the Senate) reduces its overall likelihood.
Relative to its intended legislative type, this bill is a clear and specific substantive amendment to TSCA establishing a broad prohibition on commercial asbestos with defined scope, exemptions, and procedural requirements. It integrates explicitly with existing law and anticipates several edge cases. It provides concrete mechanisms for exemptions and limited transitional authority for a specific industry.
Public health vs. economic impact: liberals emphasize health benefits; conservatives emphasize costs and disruption.
These are examples from the analysis, not a ranked list of the most-affected groups.
Public health vs. economic impact: liberals emphasize health benefits; conservatives emphasize costs and disruption.
A mainstream liberal would likely view the bill favorably as a long-sought federal ban that directly addresses the well-documented public health harms of asbestos exposure.
They would welcome the clear prohibition, the specific chemical definitions, and the narrowness of the listed exemptions compared with past weaker regulatory approaches.
They would still be critical of the chlor-alkali transition window and the national-security exemption language as potential loopholes, and would press for stronger transition supports and transparency.
A pragmatic centrist would likely support the bill’s public-health goal and the clear statutory prohibition while flagging implementation, cost, and transition issues.
They would appreciate the limited, time-bound chlor-alkali carve-out and the presidential national-security exemption as practical accommodations, but would want explicit plans for industry transition, enforcement, and fiscal impacts.
Centrists would look for cost estimates, stakeholder engagement (industry and labor), and amendments to ensure predictable implementation and minimal unintended economic disruption.
A mainstream conservative would be cautious or skeptical, acknowledging asbestos health risks but concerned about broad federal prohibition, regulatory costs, and disruption to chemical and manufacturing sectors.
They would see the bill as significant federal intervention into industry and worry about economic impacts, supply-chain disruptions, job losses, and potential unintended consequences for small businesses.
They would also criticize limits on EPA waiver authority under TSCA section 22 and may push for longer transition periods, compensation mechanisms, or preservation of state flexibility.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone, this is a targeted public‑health regulatory ban with built‑in, narrowly tailored exemptions and few structural complexities — features that improve tractability. However, affected industrial interests, transition costs, litigation risk, and the lack of appropriations or implementation funding create friction. The bill's narrow scope and compromise elements increase plausibility of eventual enactment, but overcoming stakeholder opposition and securing bipartisan supermajorities where required (e.g., in the Senate) reduces its overall likelihood.
The bill has not accumulated any surfaced votes yet.
Public health vs. economic impact: liberals emphasize health benefits; conservatives emphasize costs and disruption.
On content alone, this is a targeted public‑health regulatory ban with built‑in, narrowly tailored exemptions and few structural complexiti…
Relative to its intended legislative type, this bill is a clear and specific substantive amendment to TSCA establishing a broad prohibition on commercial asbestos with defined scope, exemptions, and procedural requireme…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.